REGENXBIO Inc. short interest in 2022
In 2022, REGENXBIO Inc.'s disclosed short interest ran from 7.20% of shares outstanding on 14 Jan 2022 to 6.45% on 30 Dec 2022, a change of -0.75 percentage points. The year's high was 8.48% on 29 Apr 2022 and its low 5.31% on 30 Nov 2022, averaging 6.88% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.75 days on 31 Aug 2022. Full history: REGENXBIO Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 7.20% (14 Jan 2022)
- End of year
- 6.45% (30 Dec 2022)
- Change
- -0.75 pp
- High
- 8.48% (29 Apr 2022)
- Low
- 5.31% (30 Nov 2022)
- Average
- 6.88%
- Highest days to cover
- 12.75 (31 Aug 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 7.20% | 7.18 | |
| 31 Jan 2022 | 7.16% | 8.02 | |
| 15 Feb 2022 | 5.85% | 4.74 | |
| 28 Feb 2022 | 7.35% | 8.13 | |
| 15 Mar 2022 | 6.84% | 6.84 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 6.40% | 7.59 | |
| 14 Apr 2022 | 7.06% | 8.07 | |
| 29 Apr 2022 | 8.48% | 10.25 | |
| 13 May 2022 | 7.39% | 6.46 | 10-Q filed, results (8-K) |
| 31 May 2022 | 7.26% | 8.59 | |
| 15 Jun 2022 | 7.43% | 8.74 | |
| 30 Jun 2022 | 7.57% | 5.21 | |
| 15 Jul 2022 | 7.16% | 7.86 | |
| 29 Jul 2022 | 7.91% | 9.90 | |
| 15 Aug 2022 | 7.72% | 9.13 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 7.24% | 12.75 | |
| 15 Sep 2022 | 6.81% | 8.22 | |
| 30 Sep 2022 | 6.75% | 7.26 | |
| 14 Oct 2022 | 5.94% | 6.49 | |
| 31 Oct 2022 | 6.17% | 8.51 | |
| 15 Nov 2022 | 5.81% | 6.20 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 5.31% | 10.42 | |
| 15 Dec 2022 | 5.89% | 8.44 | |
| 30 Dec 2022 | 6.45% | 5.21 |
See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.